Literature DB >> 27310729

Effects of phillyrin and forsythoside A on rat cytochrome P450 activities in vivo and in vitro.

Yanwen Cheng1, Xiaoling Liang1, Liying Feng1, Duo Liu2, Mengnan Qin1, Shuang Liu1, Gaofeng Liu1, Mei Dong2.   

Abstract

1. Phillyrin and forsythoside A are two important active ingredients in Forsythia suspensa. However, the effects of phillyrin and forsythoside A on the activities of cytochrome P450 (CYP450) remain unclear. 2. This study aimed to investigate the effects of phillyrin and forsythoside A on the activities of CYP1A2, CYP2C11, CYP2D1 and CYP3A1/2 by cocktail probe drugs in rats both in vivo and in vitro. 3. Many pharmacokinetic parameters of caffeine and metoprolol in phillyrin pretreatment group, caffeine and tolbutamide in forsythoside A pretreatment group were affected significantly. In rat liver microsomal incubation system, the concentrations of acetaminophen and dextrophan in the phillyrin pretreatment group are higher than blank control group by 207.69% and 125.00%, however, the concentrations of 4-hydroxytolbutamide and 6β-hydroxytestosterone were not significantly altered. The concentrations of acetaminophen and 4-hydroxytolbutamide in the forsythoside A pretreatment group are higher than blank control group by 223.07% and 154.16%, whereas the concentrations of dextrophan and 6β-hydroxytestosterone were not significantly altered. 4. These results indicated that Phillyrin had potential inductive effects on rat CYP1A2 and CYP2D1 activities, without affecting CYP2C11 and CYP3A1/2 activities. Moreover, forsythoside A had inductive effects on the activities of CYP1A2 and CYP2C11, without affecting CYP2D1 and CYP3A1/2 activities.

Entities:  

Keywords:  CYP1A2; CYP2C11; CYP2D1; CYP3A1/2; cytochrome P450; forsythoside A; phillyrin

Mesh:

Substances:

Year:  2016        PMID: 27310729     DOI: 10.1080/00498254.2016.1193262

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  8 in total

1.  Effect of Gambogenic Acid on Cytochrome P450 1A2, 2B1 and 2E1, and Constitutive Androstane Receptor in Rats.

Authors:  Jing Sun; Xiaozhu Tang; Qianqian Xu; Tao Ge; Daiyin Peng; Weidong Chen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-12       Impact factor: 2.441

Review 2.  Common Pathogenesis of Acne Vulgaris and Atherosclerosis.

Authors:  Hao Jiang; Changyi Li
Journal:  Inflammation       Date:  2019-02       Impact factor: 4.092

Review 3.  Forsythiae Fructus: A Review on its Phytochemistry, Quality Control, Pharmacology and Pharmacokinetics.

Authors:  Zhanglu Dong; Xianyuan Lu; Xueli Tong; Yaqian Dong; Lan Tang; Menghua Liu
Journal:  Molecules       Date:  2017-09-04       Impact factor: 4.411

4.  Phillyrin Attenuates Osteoclast Formation and Function and Prevents LPS-Induced Osteolysis in Mice.

Authors:  Jing Wang; Gang Chen; Qianqian Zhang; Fuli Zhao; Xiaolu Yu; Xuemei Ma; Mei Liu
Journal:  Front Pharmacol       Date:  2019-10-17       Impact factor: 5.810

5.  Drug-drug interaction of acetaminophen and roxithromycin with the cocktail of cytochrome P450 and hepatotoxicity in rats.

Authors:  Xiang Liu; Chen Chen; Xiaoying Zhang
Journal:  Int J Med Sci       Date:  2020-02-04       Impact factor: 3.738

Review 6.  Toxicity as prime selection criterion among SARS-active herbal medications.

Authors:  Franz Oesch; Barbara Oesch-Bartlomowicz; Thomas Efferth
Journal:  Phytomedicine       Date:  2021-01-28       Impact factor: 5.340

7.  Evaluation of Zhenwu Decoction Effects on CYP450 Enzymes in Rats Using a Cocktail Method by UPLC-MS/MS.

Authors:  Li-Li Hong; Qian Wang; Ya-Ting Zhao; Sheng Zhang; Kai-Qi Zhang; Wei-Dong Chen; Can Peng; Li Liu; Hong-Song Wang
Journal:  Biomed Res Int       Date:  2020-05-12       Impact factor: 3.411

8.  Phillyrin Relieves Lipopolysaccharide-Induced AKI by Protecting Against Glycocalyx Damage and Inhibiting Inflammatory Responses.

Authors:  Dong Zhang; Boyang Qi; Dongxiao Li; Jiali Feng; Xiao Huang; Xiaohong Ma; Lina Huang; Xiaozhi Wang; Xiangyong Liu
Journal:  Inflammation       Date:  2020-04       Impact factor: 4.092

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.